• / Free eNewsletters & Magazine
  • / My Account
Home>Drug Companies

Drug Companies

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit

    IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit

  2. RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second Phase 2 Clinical Compound

    RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second Phase 2 Clinical Compound

  3. RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301

    RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301

  4. Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers

    Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers

  5. CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma

    CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma

  6. Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157

    Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157

  7. Lieff Cabraser Reminds Salix Pharmaceuticals , Inc. Investors of January 6, 2015 Lead Plaintiff Deadline in Class Litigation - SLXP

    Lieff Cabraser Reminds Salix Pharmaceuticals , Inc. Investors of January 6, 2015 Lead Plaintiff Deadline in Class Litigation - SLXP

  8. Research and Markets: Lactose: Confectionery, Pharmaceuticals , Functional Foods - 2014 Global Strategic Business Report

    Research and Markets: Lactose: Confectionery, Pharmaceuticals , Functional Foods - 2014 Global Strategic Business Report

  9. Research and Markets: Gelatin: Food & Beverage, Pharmaceuticals , and Others - 2014 Global Strategic Business Report

    Research and Markets: Gelatin: Food & Beverage, Pharmaceuticals , and Others - 2014 Global Strategic Business Report

  10. Fitch Affirms Teva's Ratings at 'BBB+'; Outlook Stable

    Fitch Affirms Teva's Ratings at 'BBB+'; Outlook Stable

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.